Mckinley Capital Management LLC Invitae Corp Transaction History

Mckinley Capital Management LLC

  • $558 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$24.31 - $33.6 $1.85 Million - $2.56 Million
-76,170 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$39.09 - $57.4 $1.14 Million - $1.67 Million
29,059 Added 61.68%
76,170 $3.19 Million
Q3 2020

Nov 02, 2020
BUY
$28.43 - $44.67 $1.34 Million - $2.1 Million
47,111 New
47,111 $2.04 Million

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Mckinley Capital Management LLC Portfolio

Follow Mckinley Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Mckinley Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email